News and Media Purdue Pharma Announces Landmark Agreement with Oklahoma to Advance the Treatment of Addiction Settlement will establish national center for addiction studies and treatment in Tulsa; Sackler family announces voluntary contribution to support national...
News and Media FDA Grants Purdue Pharma’s Nalmefene HCl Injection Fast Track Designation for the Emergency Treatment of Known or Suspected Opioid Overdose Committed to advancing solutions to the opioid public health crisis, Purdue will not profit from nalmefene HCl...
When you access any of our websites, related other parities’ websites, mobile applications, or any electronic service, we may use cookies and other technologies to automatically collect information regarding you and your device to assess user activity and preferences. We may also use third-party analytic tools to assist with the collection of information including, but not limited to, Google Analytics. By using this site, you agree to our use of these technologies in accordance with our Privacy Policy.Ok
Privacy Policy Updates
Please read carefully the Purdue Pharma L.P. Privacy Policy (the “Privacy Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parities’ websites, mobile applications, or any electronic service (collectively, the “Service”). This Privacy Policy describes the information collected through Your use of the Service, how we use it, how we share it, how we protect it, and the choices You can make about Your information.
